Delving deeper into the mechanism, there is a hypothesis suggesting that SLAMF1 loss in CLL could perturb genetic routes that control chemotaxis, autophagy, and responses to treatment [27,28]. This evidence concerns the gene SLAMF1 and B-cell chronic lymphocytic leukemia.